Microiontophoretic studies of angiotensin II and prostaglandin E2. Effects on neurons of the sensorimotor cortex in rabbits. 1982

V V Sherstnev, and J I Deleva, and A I Gromov, and N A Nicolov, and K V Sudakov, and J Z Anisimov

UI MeSH Term Description Entries
D008297 Male Males
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D002682 Chinchilla A genus of the family Chinchillidae which consists of three species: C. brevicaudata, C. lanigera, and C. villidera. They are used extensively in biomedical research. Chinchillas
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015232 Dinoprostone The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2

Related Publications

V V Sherstnev, and J I Deleva, and A I Gromov, and N A Nicolov, and K V Sudakov, and J Z Anisimov
January 1977, Prostaglandins,
V V Sherstnev, and J I Deleva, and A I Gromov, and N A Nicolov, and K V Sudakov, and J Z Anisimov
August 2002, Pathophysiology : the official journal of the International Society for Pathophysiology,
V V Sherstnev, and J I Deleva, and A I Gromov, and N A Nicolov, and K V Sudakov, and J Z Anisimov
April 1982, The American journal of cardiology,
V V Sherstnev, and J I Deleva, and A I Gromov, and N A Nicolov, and K V Sudakov, and J Z Anisimov
January 1985, Prostaglandins,
V V Sherstnev, and J I Deleva, and A I Gromov, and N A Nicolov, and K V Sudakov, and J Z Anisimov
February 1983, Neuroendocrinology,
V V Sherstnev, and J I Deleva, and A I Gromov, and N A Nicolov, and K V Sudakov, and J Z Anisimov
August 1984, Journal of hypertension,
V V Sherstnev, and J I Deleva, and A I Gromov, and N A Nicolov, and K V Sudakov, and J Z Anisimov
September 1988, Prostaglandins,
V V Sherstnev, and J I Deleva, and A I Gromov, and N A Nicolov, and K V Sudakov, and J Z Anisimov
September 1996, Danish medical bulletin,
V V Sherstnev, and J I Deleva, and A I Gromov, and N A Nicolov, and K V Sudakov, and J Z Anisimov
December 2008, Experimental physiology,
V V Sherstnev, and J I Deleva, and A I Gromov, and N A Nicolov, and K V Sudakov, and J Z Anisimov
January 1984, Nihon Jinzo Gakkai shi,
Copied contents to your clipboard!